Skip to content
Head to head

Pacific Biosciences of California vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: PACB · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

PACB +3.8%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
PACBABT
Snapshot
SectorMedical DevicesMedical Devices
Last price1.63103.00
Change today-7.39%-0.84%
1-year return-13.3%-15.4%
Market cap$510.07M$178.39B
52-week range1.07 – 3.4480.89 – 126.70
Valuation
P/E (TTM)-3.8838.29
P/E percentile, own 5-yr range47th99th
P/B-8.323.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-1.823.72
Net profit (TTM)$-569.53M$6.44B
Revenue (TTM)$161.39M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+5.5%+14.5%
Gross margin34.4%56.9%
Operating margin-100.1%13.8%
Net margin-81.3%9.7%
Free cash flow (TTM)$-150.45M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership80.1%81.2%
Insider activity (12mo)35 buy / 14 sell36 buy / 12 sell
Short interest (% of float)17.3%1.1%
Analyst consensus40% buy / 40% hold / 20% sell (5)93% buy / 7% hold (15)
Analyst price target$3 (+62%)$122 (+18%)
StockVane view
StockVane Quant RatingD (32)D (22)
Company
Employees485115,000
Founded20001900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.